Who has invested in Vascular Therapies?

Fortune 100 global healthcare company are named among the investors backing Vascular Therapies.

Vascular Therapies Funding: $55M Raised, Series B (2022)

Vascular Therapies funding overview

Vascular Therapies is based in Cresskill, New Jersey. Vascular Therapies has raised $55M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in March 2022. The round record for Vascular Therapies runs through 2022; nothing later has been disclosed. Investors on record include Fortune 100 global healthcare company.

Vascular Therapies at a glance

Total raised: $55M
Latest round: Series B
Latest round date: March 2022
Headquarters: Cresskill, New Jersey
Notable investors: Fortune 100 global healthcare company

Frequently asked about Vascular Therapies funding

How much has Vascular Therapies raised?: Vascular Therapies has raised $55M in total disclosed funding across the rounds on record.
Who has invested in Vascular Therapies?: Fortune 100 global healthcare company are named among the investors backing Vascular Therapies.
What was the latest Vascular Therapies funding round?: The most recent disclosed round is a Series B, announced in March 2022.
Where is Vascular Therapies based?: Vascular Therapies is based in Cresskill, New Jersey.
When did Vascular Therapies last raise?: The last disclosed Vascular Therapies round closed in March 2022 at Series B.

We update the Vascular Therapies record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Cresskill and their backers are listed below.

Vascular Therapies Funding: $55M Raised, Series B (2022)

Vascular Therapies funding overview

Vascular Therapies at a glance

Frequently asked about Vascular Therapies funding

Companies related to Vascular Therapies (30)

Browse related funding lists (3)